May 9, 2026

Wegovy

Centre warns pharma companies against promoting weight-loss drugs among public through ads – The Times of India

Centre warns pharma companies against promoting weight-loss drugs among public through ads – The Times of India

admin03 mins

NEW DELHI: The Centre has warned pharmaceutical companies against promoting prescription weight-loss GLP-1 drugs – popularly sold under brand names Ozempic, Wegovy and Mounjaro – through advertisements or “disease awareness” campaigns that indirectly encourage their use among the public.In an advisory, Central Drugs Standard Control Organisation said it had come to its notice that some…

Read More
Oprah Winfrey Weight Loss: Oprah Winfrey’s slim look at Paris Fashion Week sparks talk about GLP-1 weight loss | English Movie News – The Times of India

Oprah Winfrey Weight Loss: Oprah Winfrey’s slim look at Paris Fashion Week sparks talk about GLP-1 weight loss | English Movie News – The Times of India

admin05 mins

Oprah Winfrey turned heads at Paris Fashion Week with her stunning new look, featuring a noticeably slimmer silhouette that has set social media abuzz. Her remarkable transformation, linked to GLP-1 medications such as Ozempic, has reignited debates surrounding celebrity weight loss journeys and the impact of cosmetic enhancements, captivating fans and critics alike across the…

Read More
The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating America’s wasteline | – The Times of India

The Needle and the Nation: How Ozempic, Wegovy, Mounjaro, and other GLP-1 drugs are quietly deflating America’s wasteline | – The Times of India

admin09 mins

Some revolutions don’t start with flags or hashtags. They start with a needle. No this isn’t a Danny Boyle reference to Trainspotting, the heroin classic that was cinematic perfection before Ewan McGregor graduated to become Obi-Wan Kenobi. But, America’s latest cultural export isn’t a Marvel sequel or a TikTok trend — it’s a syringe. Across…

Read More
Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments – The Times of India

Novo Nordisk to cut 9,000 jobs: Ozempic maker to reduce workforce by 11%; refocus on diabetes and obesity treatments – The Times of India

admin03 mins

Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to reduce its global workforce by 11 percent, eliminating 9,000 positions, including 5,000 in Denmark. The move aims to save eight billion kroner ($1.3 billion) as competition intensifies for its anti-obesity treatments Ozempic and Wegovy, as reported by AFP.The company also lowered its earnings forecast for…

Read More